EASIX-1year and late mortality after allogeneic stem cell transplantation

Patients with hematological malignancies who survive the first year after allogeneic stem cell transplantation (allo-SCT) without relapse have a substantial risk of nonrelapse mortality (NRM) and missing predictive markers. The Endothelial Activation and Stress Index (EASIX) predicts endothelial com...

Descripción completa

Detalles Bibliográficos
Autores principales: Kordelas, Lambros, Terzer, Tobias, Gooley, Ted, Davis, Chris, Sandmaier, Brenda M., Sorror, Mohamed, Penack, Olaf, Schaeper, Nigel D. E., Blau, Igor W., Beelen, Dietrich, Radujkovic, Aleksandar, Dreger, Peter, Luft, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509665/
https://www.ncbi.nlm.nih.gov/pubmed/37477588
http://dx.doi.org/10.1182/bloodadvances.2022008617

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509665/
https://www.ncbi.nlm.nih.gov/pubmed/37477588
http://dx.doi.org/10.1182/bloodadvances.2022008617

Ejemplares similares